AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05499559 — intervention group
Intervention type: BEHAVIORAL
Intervention: Joint Academy digital treatment
Description: The Joint Academy® (www.jointacademy.com) program for people with hand OA consists of video instructed and progressively adaptable daily exercises, patient education through text lessons, possibility for a social chat group with other patients and a continuous asynchronous chat function with a personal reg. physiotherapist who supervises the patient during the full participation period. The program also contains three telephone consultations with a physiotherapist that were compulsory, one at the start, one after six weeks and one after three months.
Study NCT05846841 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Precision Treatment
Description: Precision treatment will be informed by practice guidelines (standard of care, brief advice, and guideline awareness), plus patient-specific risk feedback and personalized tobacco treatment recommendations using patients' clinical, genetic, and biomarker information.
Study NCT05846841 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual care will be informed by practice guidelines (standard of care, brief advice, and guideline awareness).
Study NCT04566042 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy video game
Description: The intervention is a videogame which teaches the participant about acceptance and commitment therapy.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1RLD
Description: 1RLD=One text per day, ramped goal, loss incentive, daily goal time period
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1RLW
Description: 1RLW=One text per day, ramped goal, loss incentive, weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1RGD
Description: 1RGD=One text per day, ramped goal, gain incentive, daily goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1RGW
Description: One text per day, ramped goal, gain incentive, weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2RLD
Description: Two texts per day, ramped goal, loss incentive, daily goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2RLW
Description: Two texts per day, ramped goal, loss incentive, weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2RGD
Description: Two texts per day, ramped goal, gain incentive, daily goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2RGW
Description: Two texts per day, ramped goal, gain incentive, weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1FLD
Description: One text per day, fixed goal, loss incentive, daily weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1FLW
Description: One text per day, fixed goal, loss incentive, weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1FGD
Description: One text per day, fixed goal, gain incentive, daily goal time period.
Study NCT04793867 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Xenon
Description: Subjects will be scanned on a commercial 3T whole-body MRI scanner equipped with high-performance gradient systems. Natural isotopic abundance or isotopically-enriched xenon gas (\~86% 129Xe, Linde Inc.) will be used for all studies. Subjects will be positioned supine in the scanner with a 129Xe RF coil around their chests. Using conventional proton MRI and a breath-hold acquisition, scout images will be obtained to localize the subject for subsequent 129Xe acquisitions. 129Xe images will be acquired using the same breath-hold maneuver and a pulse sequence, covering the entire lung (acquisition time \<10 s, approximately 3-mm in-plane resolution, 15-mm slice thickness or less). Additional scans (sequences) may be performed. A maximum of 4 doses of 129Xe will be given throughout the study following the calibration dose.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1FGW
Description: One text per day, fixed goal, gain incentive, weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2FLD
Description: Two texts per day, fixed goal, loss incentive, daily goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2FLW
Description: Two texts per day, fixed goal, loss incentive, weekly goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2FGD
Description: Two texts per day, fixed goal, gain incentive, daily goal time period.
Study NCT04874415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2FGW
Description: Two texts per day, fixed goal, gain incentive, weekly goal time period.
Study NCT04983537 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gam-COVID-Vac / Gam-COVID-Vac
Description: A comparison of antibody levels against protein S will be performed using the Gam-COVID-Vac / Gam-COVID-Vac group as a control group and the Gam-COVID-Vac / ChAdOx1 nCoV-19 and Gam-COVID-Vac / BBIBP-CorV groups as comparators.Comparisons will be made by contrasting the geometric means of antibody levels between each of the study arms. In addition, comparisons will be made as to whether or not the median antibody values of the alternative treatment groups are lower than: a) the 25th percentile of the median antibody value of the Gam COVID combination and b) whether the lower limit of the confidence interval of the differences in the GMC rate is lower than the conventional cut-off point of non-inferiority set at 0.67.
Study NCT05767099 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound mesurements
Description: Compare various clinical test with ultrasound parameters to predict difficult videolaryngoscopy intubation.
Study NCT06243588 — intervention group
Intervention type: OTHER
Intervention: clinical records review
Description: review the medical records, radiological imaging, and histological data of these patients
Study NCT05095051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paxman Cryocompression System (PCCS)
Description: Establishing optimal temperature and pressure for limb cryocompression therapy. Healthy subjects will undergo 3 hours of limb cryocompression.~The cryocompression device used in this study consists of a control unit, and limb wraps. The control unit contains the coolant reservoir and pump to circulate the coolant and air for compression. It is able to thermoregulate (control the temperature of the circulating coolant) and offer cyclic air pressure in the wraps. The wraps cover the limbs from the elbow/knee to the fingers/toes.
Study NCT05095051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paxman Cryocompression System (PCCS)
Description: The study population will comprise of cancer patients scheduled to receive weekly paclitaxel chemotherapy for a maximum of 12 cycles.~Paclitaxel will be administered as a one-hour infusion. Limb cryocompression sessions comprised of a pre-cooling period (up to one hour), continued with paclitaxel infusion and a post-cooling period (on average 30 minutes after the end of paclitaxel infusion). Overall, limb cryocompression will be administered for no longer than four hours.
Study NCT01441453 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: FibroScan (Transient Elastography measurement)
Description: Preoperative evaluation of liver stiffness through FibroScan
Study NCT05599256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Description: Model-predicted high-risk patients: weight ≤ 25 kg, ruxolitinib, 2.5mg bid po until at least day 60 post-transplant and terminated after day 100; weight > 25 kg, ruxolitinib, 5mg bid po until at least day 60 post-transplant and terminated after day 100. If 'azoles' are taken concomitantly, ruxolitinib will start at half dose. If the patient tolerates ruxolitinib, the dose can be increased to 10mg bid po.~Model-predicted low risk: regular aGVHD prophylactic regimens.
Study NCT05228158 — intervention group
Intervention type: DRUG
Intervention: Tazemetostat
Description: Tazemetostat oral tablets.
Study NCT04512716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131-I Apamistamab
Description: Patients will receive 131-I apamistamab 5-7 days prior to a single infusion of 1x10\^6 19-28z CAR T-cells/kg for those in the B-ALL cohort, or 2x10\^6 19-28z CAR T-cells/kg, for those in the DLBCL. 131-I apamistamab may be administered inpatient or outpatient at the discretion and judgment of the treating investigators.
Study NCT04512716 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR T-cell
Description: 19-28z CAR T-cells will be administered inpatient as a single infusion of 1x10\^6 19-28z CAR T-cells/kg, for those in the B-ALL cohort, or 2x10\^6 19-28z CAR T-cells/kg, for those in the DLBCL cohort. Patients will be observed inpatient for a minimum of 7 days (longer as clinically indicated and at the discretion of the treating physician).
Study NCT04726241 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood and/or bone marrow samples
Study NCT05738655 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pumpkin seed extract (Low dose)
Description: Pumpkin seed extract standardized with specific peptides (300 mg/day)
Study NCT05738655 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pumpkin seed extract (High dose)
Description: Pumpkin seed extract standardized with specific peptides (600 mg/day)
Study NCT05738655 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placeo (300 mg/day)
Study NCT04897191 — intervention group
Intervention type: OTHER
Intervention: Age
Description: Determination of age-dependence
Study NCT05650268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Description: Receiving 576000 international units in single oral dose of liquid vitamin D 3\~7 days prior to the surgery.
Study NCT06433583 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcutaneous auricular vagal nerve stimulation
Description: The use of TENS ECO PLUS and the vagus nerve ear electrode medical devices for transcutaneous auricular vagal nerve stimulation (taVNS) everyday for 10 minutes twice a day or 20 minutes for 8 successive weeks. Patients are included at week 0, use taVNS between week 2 and 10, and are followed up until week 22.~Patient adherence: percentage of patients performing 20 minutes of daily stimulation on at least 5 days a week for at least 6 cumulative weeks.
Study NCT05650268 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 95% MCT
Description: 95% MCT supplement 3-7 day before surgery
Study NCT05119582 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TOOsonix System ONE-M
Description: Selected neurofibromas will be treated by high intensity focused ultrasound. Untreated fibromas will be used for controls.
Study NCT06069323 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive Transcranial Magnetic Stimulation
Description: Pediatric patients with ASD and ADHD will be randomized both in active and sham groups.
Study NCT04972825 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mind the Gap
Description: This intervention will help parents with children newly diagnosed with autism or other neurodevelopmental disorders learn how to navigate the system of acquiring services for their child. These parents will be assisted by a coach, an employee at the child's agency, that will help them through this process.
Study NCT04972825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mind the Gap
Description: This intervention will help parents with children newly diagnosed with autism or other neurodevelopmental disorders learn how to navigate the system of acquiring services for their child. These parents will be assisted by a coach, an employee at the child's agency, that will help them through this process.
Study NCT06553508 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trochanteric bursa repaired
Description: As a routine procedure in our centre, the trochanteric bursa is left unrepaired after a hip arthroplasty.
Study NCT06553508 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Trochanteric bursa unrepaired
Description: For the experimental arm, the trochanteric bursa is repaired after a hip arthroplasty. The conventional joint closure is performed after reduction and then the bursa is retrieved and repaired.
Study NCT06395558 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Description: Multimodal web-based intervention programme on anxiety, depression and cognitive impairment consisting of knowledge development sessions and practical/gaming sessions focused on different domains: cognitive competence, socio-relational competence and emotions/affectivity, and physical activity-nutrition
Study NCT04704544 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-rheumatology
Description: Participants will receive virtual visits via video conferencing and/or phone.
Study NCT05520268 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional music therapy (CMT)
Description: CMT comprises both receptive and expressive musical activities (listening and reminiscing to music, singing, and moving to music) held in small groups (8 PWDs/group) for a duration of 10 weeks (2x60 min sessions/week) and led by a professional music therapist. For PWDs living in a care home, the CMT sessions are implemented as inpatient rehabilitation held at the care home. For PWDs living at home, the CMT sessions are implemented as outpatient rehabilitation held at a local day activity centre.
Study NCT06069323 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive Transcranial Magnetic Stimulation
Description: Pediatric patients with ASD and ADHD will be randomized both in active and sham groups.
Study NCT06290219 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: platelet-rich plasma combined with hyaluronic acid
Description: The project investigator injects plasma mixed with hyaluronic acid into the nasal septum and the medial side of the middle turbinate of the patient's nasal cavity under a nasal endoscope.
Study NCT05756322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBS-007
Description: Open Label.
Study NCT06391268 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Technique (EFT) works on cognitive and energetic levels.
Description: Emotional Freedom Technique (EFT) works on cognitive and energetic levels.
Study NCT05575466 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood samples
Description: Hemostatic biomarkers
Study NCT06290219 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zinc Gluconate 10 MG Oral Tablet
Description: one tablet three times a day for a period of 12 weeks
Study NCT05575466 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaires
Description: Eating Disorder Inventory - third version (EDI-3) Eating Disorder Quality of Life Scale (EDQLS)
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06290219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc Gluconate 10 MG Oral Tablet
Description: one tablet three times a day for a period of 12 weeks
Study NCT06290219 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 4 bottles of phenyl ethyl alcohol, lemon, eucalyptus, and clove oil
Description: Sniffing each odorant for 10 seconds, twice a day for 12 weeks
Study NCT06290219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 4 bottles of phenyl ethyl alcohol, lemon, eucalyptus, and clove oil
Description: Sniffing each odorant for 10 seconds, twice a day for 12 weeks
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Scan
Description: Undergo bone scan
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study NCT06470243 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cabazitaxel
Description: Given IV
Study NCT04353024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dimethyltryptamine (DMT)
Description: Intravenous DMT bolus and/or DMT maintenance perfusion over 90 min
Study NCT04353024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline
Description: Intravenous saline bolus and/or saline maintenance perfusion over 90 min
Study NCT04353024 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Intravenous saline bolus and/or saline maintenance perfusion over 90 min
Study NCT06470243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Description: Given IV
Study NCT06470243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chest Radiography
Description: Undergo chest x-ray
Study NCT05520268 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital music rehabilitation (DMR)
Description: DMR comprises both receptive and expressive musical activities (listening and reminiscing to music, singing, and moving to music) held in small groups (8 PWDs/group) for a duration of 10 weeks (2x60 min sessions/week) and implemented using a novel digital music content service called HILDA. In HILDA, there are a number of stand-alone musical programs hosted by a virtual presenter which the PWDs can follow and through which they can interact. The DMR sessions are moderated by an instructor (care home staff member or research assistant). For PWDs living in a care home, the DMR is implemented as live sessions held at the care home using a HILDA box connected to a TV screen and operated via a remote controller by the instructor. For PWDs living at home, the DMR is implemented as virtual sessions using a video communication platform that allows the instructor to stream and control the HILDA service and the participants to see and hear each other and interact.
Study NCT05470829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZM-H1505R
Description: Part 1 dosage form:75mg dosage:Tablet frequency: Quaque die duration: Day1; Day 4\~ Day 14~Cohort 1 of Part 2 dosage form:50mg dosage:Tablet frequency: Quaque die duration: Day 1\~ Day 28~Cohort 2 of Part 2 dosage form:100mg dosage:Tablet frequency: Quaque die duration: Day 1\~ Day 28~Cohort 3 of Part 2 dosage form:200mg dosage:Tablet frequency: Quaque die duration: Day 1\~ Day 28
Study NCT05470829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ZM-H1505R Placebo
Description: Part 1 dosage form:75mg dosage:Tablet frequency: Quaque die duration: Day1; Day 4\~ Day 14~Cohort 1 of Part 2 dosage form:50mg dosage:Tablet frequency: Quaque die duration: Day 1\~ Day 28~Cohort 2 of Part 2 dosage form:100mg dosage:Tablet frequency: Quaque die duration: Day 1\~ Day 28~Cohort 3 of Part 2 dosage form:200mg dosage:Tablet frequency: Quaque die duration: Day 1\~ Day 28
Study NCT05668260 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biodegradable Stent
Description: A trans-anastomotic biodegradable internal stent (ARCHIMEDES™) will be placed between the main pancreatic duct (MPD) and the enterotomy in the jejunum just after the completion of the posterior suture of duct-to-mucosa. The biodegradable stent will then be shaped according to the angle of the jejunal loop in order to minimise the risk of displacement. The adequate length of the stent will be chosen according to the length of the jejunal loop.
Study NCT04683718 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Permanent implant of a BIOTRONIK Prospera SCS (Spinal Cord Stimulation) System with HomeStream Remote Management
Description: The Prospera SCS System is a rechargeable, 16-electrode, MRI conditional Spinal Cord Stimulation system that delivers electrical stimulation to the dorsal column of the spinal cord for the treatment of chronic intractable pain of the trunk and/or limbs.
Study NCT04489485 — intervention group
Intervention type: BEHAVIORAL
Intervention: Teen Depression Module used for care
Description: All teens coming for routine well child care to the enhanced group PCPs will have depression screening with strengths and goals and a depression screen with follow up suggestions for activities to help any depression symptoms, and treatment using the Teen Depression Module and offered a depression chabot. Suicide screening will be conducted.
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chest Radiography
Description: Undergo chest x-ray
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT or PET/CT
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET/CT